Integer Holdings Corporation $ITGR Position Lessened by Gabelli Funds LLC

Key Points

• Gabelli Funds LLC reduced its holdings in Integer Holdings Corporation by 6.3%, now owning 60,000 shares valued at approximately $7.08 million.
• Institutional investors and hedge funds collectively own 99.29% of Integer's stock, with significant increases from Northern Trust Corp and new stakes from other firms.
• Integer's recent earnings report revealed $1.55 EPS, slightly missing estimates, while revenues surged 11.4% year-over-year to $476 million.

Gabelli Funds LLC lowered its position in Integer Holdings Corporation (NYSE:ITGR - Free Report) by 6.3% in the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 60,000 shares of the medical equipment provider's stock after selling 4,000 shares during the period. Gabelli Funds LLC owned 0.17% of Integer worth $7,081,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Stifel Financial Corp grew its position in Integer by 2.4% during the fourth quarter. Stifel Financial Corp now owns 32,290 shares of the medical equipment provider's stock valued at $4,279,000 after buying an additional 772 shares during the period. Hsbc Holdings PLC grew its holdings in shares of Integer by 115.8% in the fourth quarter. Hsbc Holdings PLC now owns 12,562 shares of the medical equipment provider's stock worth $1,676,000 after purchasing an additional 6,741 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of Integer by 14.4% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 22,957 shares of the medical equipment provider's stock valued at $3,043,000 after buying an additional 2,891 shares during the period. Northern Trust Corp increased its holdings in shares of Integer by 14.2% in the 4th quarter. Northern Trust Corp now owns 422,380 shares of the medical equipment provider's stock valued at $55,974,000 after acquiring an additional 52,556 shares during the period. Finally, Lido Advisors LLC grew its holdings in Integer by 31.4% in the fourth quarter. Lido Advisors LLC now owns 2,742 shares of the medical equipment provider's stock worth $363,000 after purchasing an additional 655 shares during the last quarter. Institutional investors own 99.29% of the company's stock.

Integer Stock Down 0.9%

Shares of NYSE:ITGR traded down $0.94 during trading on Tuesday, hitting $106.93. The company's stock had a trading volume of 143,519 shares, compared to its average volume of 469,445. The company has a market capitalization of $3.75 billion, a PE ratio of 47.10, a PEG ratio of 0.85 and a beta of 1.03. Integer Holdings Corporation has a fifty-two week low of $104.93 and a fifty-two week high of $146.36. The company has a debt-to-equity ratio of 0.72, a quick ratio of 2.18 and a current ratio of 3.41. The stock's 50-day moving average price is $112.48 and its two-hundred day moving average price is $117.58.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings data on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.02). The business had revenue of $476.00 million for the quarter, compared to analysts' expectations of $464.37 million. Integer had a return on equity of 12.27% and a net margin of 4.61%.Integer's revenue for the quarter was up 11.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.30 earnings per share. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. As a group, sell-side analysts expect that Integer Holdings Corporation will post 6.01 EPS for the current year.

Insider Transactions at Integer

In other news, Director Donald J. Spence sold 14,739 shares of the stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total transaction of $1,774,280.82. Following the transaction, the director owned 18,781 shares of the company's stock, valued at approximately $2,260,856.78. This trade represents a 43.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Martin C. Maxwell sold 8,720 shares of Integer stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total value of $1,051,283.20. Following the completion of the transaction, the director owned 22,170 shares of the company's stock, valued at approximately $2,672,815.20. The trade was a 28.23% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.16% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on ITGR shares. Citigroup raised shares of Integer from a "hold" rating to a "strong-buy" rating and raised their target price for the stock from $133.00 to $140.00 in a report on Thursday, May 22nd. Truist Financial cut their price objective on Integer from $145.00 to $137.00 and set a "buy" rating for the company in a research report on Friday, July 25th. Wall Street Zen raised Integer from a "hold" rating to a "buy" rating in a research report on Saturday. Raymond James Financial reduced their price objective on shares of Integer from $150.00 to $143.00 and set an "outperform" rating for the company in a research report on Friday, July 25th. Finally, Wells Fargo & Company dropped their price target on Integer from $152.00 to $132.00 and set an "overweight" rating on the stock in a research report on Friday, July 25th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of $140.25.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.